Skip to main content
Fig. 4 | Thrombosis Journal

Fig. 4

From: Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

Fig. 4

Percentage changes in active factor Xa concentration, PT-INR, and APTT values. A Active factor Xa concentrations at all time points. B Active factor Xa concentrations at time points 1, 3, and 5 (n = 8). C PT-INR values at all time points. D PT-INR values at time points 1, 3, and 5 (n = 8). E APTT values at all time points. F APTT values at time points 1, 3, and 5 (n = 8). Dots and error bars represent mean ± SD

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us